<DOC>
	<DOCNO>NCT00497770</DOCNO>
	<brief_summary>This large , non-randomized observational study conduct provide data impact ethnic origin outcome resource utilization 2nd line treatment non-small cell lung cancer ( NSCLC ) routine medical care setting .</brief_summary>
	<brief_title>An Observational Study Ethnic Impact Patients Undergoing Second ( 2nd ) Line Treatment Non-Small Cell Lung Cancer Using Pemetrexed</brief_title>
	<detailed_description>This large 1000 patient single arm observational study conduct determine impact ethnic origin ( Caucasian , African-Americans , Asian-Americans , Hispanics ) patient treat 2nd line advance NSCLC pemetrexed give routine clinical practice . Data collect disease control rate pemetrexed define Response Rate ( RR ) ( Complete Response ( CR ) + Partial Response ( PR ) ) , Stable Disease ( SD ) toxicity . In addition , overall survival , progression-free survival , treatment toxicity , activity daily live , symptom burden resource utilization also observe . To meet study goal , total 400 Caucasians , 200 African- Americans , 200 Asian-Americans , 200 Hispanics accrue study .</detailed_description>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Nonsmall cell lung cancer ( NSCLC ) ( histologic type ) Stage IIIB IV disease Should 1 line chemotherapy Metastatic disease Adequate hematologic , hepatic renal function Measurable evaluable disease Pregnant lactating female</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>